Fig. 1: Overall survival from the time of progression event on ibrutinib treatment.
Patients with CLL disease progression are compared to those who had Richter transformation events.
Fig. 1: Overall survival from the time of progression event on ibrutinib treatment. | Blood Cancer Journal
